Advanced Bifurcation Systems
877-413-5845
  • Home
  • About Us
    • Management
    • Board Of Directors
    • Scientific Advisory Board
    • Executive Summary
    • Investor Relations
  • The ABS Product Platform
    • Clinical Case Demonstrations
    • First Human Trial
    • Intellectual Property
  • News and Events
    • Publications
    • Blog
    • Events
  • Contact Us
  • Home
  • About Us
    • Management
    • Board Of Directors
    • Scientific Advisory Board
    • Executive Summary
    • Investor Relations
  • The ABS Product Platform
    • Clinical Case Demonstrations
    • First Human Trial
    • Intellectual Property
  • News and Events
    • Publications
    • Blog
    • Events
  • Contact Us

News and Events

ABS® News & Announcements

  • BioSpace – ABS Announces Livermore Manufacturing Facility
  • Family Office Networks Partners With ABS – says our platform may become the “standard of care”
  • MorningStar – Thomas O’Neill Joins ABS Board of Directors
  • Bloomberg- Advanced Bifurcation Add Tom O’Neill to Its Board
  • Silicon Investor – ABS Announces 2018 Expansion Plans
  • World News – ABS Amasses 34 Patents With Many More In Process
  • World News – ABS Announces Plans To Raise $20M, Appoints Ken Richards CFO

Advanced Bifurcation Systems® Press Resources

Company Profiles

Inc

Inc Profile On Advanced Bifurcation Systems

logo

ABS Profile and News On BioSpace

Patents

Patent portfolio as of Q3 2018
  • 36 Issued
    • 12 issued by the U.S. Patent Office
    • 24 International
    • Includes Patents Issued by China, Australia, UK and Canada
  • 12 Additional Patents Pending

ABS® makes the impossible possible

Simplifying bifurcation operations with short and precise stent delivery

GET IN TOUCH WITH US

Contact Us

  • 7419 Southfront Rd
    Livermore, CA 94551
  • 877-413-5845
  • 877-413-5901

Get Connected

LinkedIn YouTube

Company Profiles

img-profiles-incimg-profile-biospace

©2019 Advanced Bifurcation Systems.
All Rights Reserved.
  • Privacy Policy
  • Website by Pronto
  • Contact Us

This site and all contents are copyright © 2017 Advanced Bifurcation Systems unless otherwise noted. All information is presented for informational purposes and no specific medical claims have been made or should be implied. The company has submitted a proposal to the U.S. Federal Drug Administration (“FDA”) for a clinical study leading to an IDE for its bifurcation technology. No statements on this site have been verified by the FDA or any governing body.